MedTrace Logo

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)

NCT02324205 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2019-02-26

Study results available
· View outcomes & findings →

Summary

The aim of this recruitment plan (ADAPT-BX) is to collect image and technical data on both digital breast tomosynthesis (DBT) and full-field digital mammography (FFDM), along with other subject data including histology results from biopsy specimen examination and cancer classification data from initially asymptomatic women referred for biopsy after recall from screening and diagnostic work-up. These data will be included in a subsequent and prospectively planned pooled analysis described in a separate protocol (ADAPT-BIE) examining superiority of DBT to FFDM for breast cancer diagnosis and other clinical performance measures.

Conditions

Interventions

DEVICE

DBT and FFDM

Subjects underwent breast imaging using each device: DBT and FFDM.

Sponsors & Collaborators

  • GE Healthcare

    lead INDUSTRY

Principal Investigators

  • Corinne Balleyguier, MD · Gustave Roussy, Cancer Campus, Grand Paris

  • Lydia Liao, MD · Cooper Health

  • Kathy Schilling, MD · Boca Raton Regional Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-08-29
Completion
2017-08-29

Countries

  • United States
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02324205 on ClinicalTrials.gov